Blue Jet Healthcare Ltd, incorporated in 1968 and the first manufacturer of saccharin and its salts (artificial sweeteners) in India, is engaged in pharmaceutical and healthcare ingredients and intermediates. The company reported a decline in profits for Q2FY26.
Financial Highlights:
- Revenues decreased 20.67% year-on-year to ₹165 crore from ₹208 crore.
- Total expenses fell 15.28% to ₹122 crore from ₹144 crore.
- Consolidated net profit declined 10.34% to ₹52 crore from ₹58 crore.
- Earnings per share dropped 10.42% to ₹3.01 from ₹3.36.
The profit decline was largely driven by a significant drop in revenues, partly offset by lower expenses.
Outlook:
Blue Jet Healthcare Ltd aims to stabilize revenues by focusing on product diversification and expanding its market reach to improve future profitability.
Explore the company’s past earnings and latest concall transcripts, click here to visit the AlphaStreet India News Channel.
Most Popular
Cochin Shipyard Ltd (COCHINSHIP) Q4 FY22 Earnings Concall Transcript
Cochin Shipyard Limited (NSE:COCHINSHIP) Q4 FY22 Earnings Concall dated May. 26, 2022 Corporate Participants: Madhu S Nair -- Chairman & Managing Director Jose V J -- Director Finance Analysts: Vastupal Shah
All you need to know about Antony Waste Handling Cell in one article
Can you guess the name of the company that was listed during the IPO frenzy in 2020 and is the second largest player in the Indian municipal waste management industry?
Demystifying the Leading Non-Ferrous Recycling Company of India
“Hey, how is the market doing today?” “Oh!, its falling tremendously since morning” I am sure news like these might be a common topic of discussion for you nowadays. Interestingly,